CAH
Cardinal Health, Inc.
Cardinal Health, Inc. insider trading
Every time one of CAH's executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
SEC Form 4 data, Q3 2024 to Q2 2026
CAH insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded CAH on the open market: 0 purchases and 34 sales worth $75M. In the last four quarters alone: 0 purchases and 23 sales ($53M), by 9 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | −$2.1M4 sales | |
| Q4 2025 | — | — | |
| Q3 2025 | — | −$50.9M19 sales | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | −$432.9K1 sale | |
| Q3 2024 | — | −$21.6M10 sales |
- Largest sale
- −$14.1M of CAH by Hollar Jason M. (Chief Executive Officer) on Aug 19, 2025.
Open-market transactions through Jun 30, 2026most recent first
Greene Michelle D.
Chief Information Officer
−$604.5K
Feb 27, 2026
2,646 sh · $228.47
Greene Michelle D.
Chief Information Officer
−$22.9K
Feb 27, 2026
100 sh · $228.55
Alt Aaron E
Chief Financial Officer
−$525K
Feb 18, 2026
2,328 sh · $225.50
Hall Patricia Hemingway
Director
−$918.9K
Feb 06, 2026
4,000 sh · $229.72
Hollar Jason M.
Chief Executive Officer
−$3.5M
Aug 20, 2025
22,957 sh · $150.40
Weitzman Deborah
CEO, PSS Segment
−$3.2M
Aug 20, 2025
21,367 sh · $150.53
Hollar Jason M.
Chief Executive Officer
−$1.9M
Aug 20, 2025
12,944 sh · $149.40
Hollar Jason M.
Chief Executive Officer
−$14.1M
Aug 19, 2025
94,735 sh · $148.92
Mason Stephen M
CEO, GMPD Segment
−$5.1M
Aug 19, 2025
34,411 sh · $148.83
Alt Aaron E
Chief Financial Officer
−$5.1M
Aug 19, 2025
34,455 sh · $148.61
Mayer Jessica L
Chief Legal/Compliance Officer
−$5M
Aug 19, 2025
33,333 sh · $148.91
Snow Ola M
Chief Human Resources Officer
−$3.5M
Aug 19, 2025
23,700 sh · $148.86
Alt Aaron E
Chief Financial Officer
−$2.1M
Aug 19, 2025
13,788 sh · $149.19
Greene Michelle D.
Chief Information Officer
−$1.8M
Aug 19, 2025
11,994 sh · $148.76
Scherer Mary C.
Chief Accounting Officer
−$1M
Aug 19, 2025
6,766 sh · $149.25
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Greene Michelle D.Chief Information Officer | 2,646 | $228.47 | −$604.5K |
| Feb 27, 2026 | Greene Michelle D.Chief Information Officer | 100 | $228.55 | −$22.9K |
| Feb 18, 2026 | Alt Aaron EChief Financial Officer | 2,328 | $225.50 | −$525K |
| Feb 06, 2026 | Hall Patricia HemingwayDirector | 4,000 | $229.72 | −$918.9K |
| Aug 20, 2025 | Hollar Jason M.Chief Executive Officer | 22,957 | $150.40 | −$3.5M |
| Aug 20, 2025 | Weitzman DeborahCEO, PSS Segment | 21,367 | $150.53 | −$3.2M |
| Aug 20, 2025 | Hollar Jason M.Chief Executive Officer | 12,944 | $149.40 | −$1.9M |
| Aug 19, 2025 | Hollar Jason M.Chief Executive Officer | 94,735 | $148.92 | −$14.1M |
| Aug 19, 2025 | Mason Stephen MCEO, GMPD Segment | 34,411 | $148.83 | −$5.1M |
| Aug 19, 2025 | Alt Aaron EChief Financial Officer | 34,455 | $148.61 | −$5.1M |
| Aug 19, 2025 | Mayer Jessica LChief Legal/Compliance Officer | 33,333 | $148.91 | −$5M |
| Aug 19, 2025 | Snow Ola MChief Human Resources Officer | 23,700 | $148.86 | −$3.5M |
| Aug 19, 2025 | Alt Aaron EChief Financial Officer | 13,788 | $149.19 | −$2.1M |
| Aug 19, 2025 | Greene Michelle D.Chief Information Officer | 11,994 | $148.76 | −$1.8M |
| Aug 19, 2025 | Scherer Mary C.Chief Accounting Officer | 6,766 | $149.25 | −$1M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
After insiders bought CAH
What the stock actually did in the 90 days following each open-market purchase
Don't check CAH — let it ping you
Get told the moment an insider moves on CAH
Pro watches Cardinal Health, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add CAH to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read CAH insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- How much CAH stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 9 Cardinal Health, Inc. insiders made no open-market purchases and 34 sales worth $75M. In the four quarters to Jun 30, 2026: no purchases and 23 sales ($53M). The largest sale was Hollar Jason M. selling $14.1M on Aug 19, 2025.
- Where does CAH insider trading data come from?
- From the Form 4 filings Cardinal Health, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.